Thrombocytopenia in a patient with a mechanical aortic valve treated with low-molecular-weight heparin

Abstract

Thromboembolic complications such as systemic embolization and valve thrombosis are a major complications after mechanical valve replacement; however, the benefit of anticoagulation must be weighed against the risk of bleeding events. The management in a patient with thrombocytopenia and absolute indication for anticoagulation, such as mechanical heart valve, requires individualization of treatment taking into account a very high risk of thromboembolic complications.